ChaoHuiHuangMDFACP

Oncology • Fairway, KS

Hematologic Oncology

Associate Professor

Join to view full profile

Dr. Huang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Huang's full profile

Already have an account?

Office
2650 Shawnee Mission Pkwy
Fairway, KS 66205
Phone+1 913-588-6029

Fax+1 913-588-4085
Is this information wrong?

Education & Training

Temple University HospitalFellowship, Hematology and Medical Oncology, 1996 - 1999
University of Pennsylvania Health SystemResidency, Internal Medicine, 1992 - 1996
Federal University of Rio Grande do Sul School of MedicineClass of 1992

Certifications & Licensure

MO State Medical License 2021 - 2025
KS State Medical License 2003 - 2024
PA State Medical License 1995 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Start of enrollment: 2004 Oct 01
Completed
Phase 2
Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2007 Feb 01
Terminated
Phase 1
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer Start of enrollment: 2007 Jun 01
Terminated
Phase 2
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2008 Dec 01
Completed
Phase 2
Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy Start of enrollment: 2008 Jul 01
Unknown status
Phase 2
MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer Start of enrollment: 2009 Jun 01
Completed
Phase 2
An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Jan 01
Completed
Phase 1
S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2009 May 01
Completed
Phase 2
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Start of enrollment: 2009 Jul 15
Terminated
Phase 3
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) Start of enrollment: 2010 Jul 01
Completed
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
Terminated
Phase 2, Phase 3
Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer Start of enrollment: 2013 Sep 09
Terminated
Phase 1
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Har...
J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei, Bruna Pellini, Michael R Costello, Jonathan E Dowell, Gene Finley, Chao H Huang,...> ;Clinical Lung Cancer. 2023 Nov 1
Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
Alec S Britt, Caitlyn Huang, Chao H Huang> ;Frontiers in Oncology. 2022 Jan 1
8 citations
Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases.
Tahani Atieh, Chao H. Huang> ;Frontiers in Oncology. 2021 Jun 11
Factors Associated with Radiation Toxicity and Survival in Patients with Presumed Early-Stage Non-Small Cell Lung Cancer Receiving Empiric Stereotactic Ablative Radiot...
John L. Park, Curtis Whiting, Eashwer Reddy, Sushant Govindan, Chao Huang, Sonia M Castillo> ;Federal Practitioner. 2021 May 1
29 citations
Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review.
Chengliang Huang, Meizhang Li, Ben Liu, Huanbo Zhu, Qun Dai, Xianming Fan, Kathan Mehta, Chao Huang, Prakash Neupane, Fen Wang, Weijing Sun, Shahid Umar, Cuncong Zhong...> ;Frontiers in Oncology. 2021 Mar 18
Outcomes in older patients with NSCLC receiving immunotherapy: A single center experience.
Jacob Ripp, Ghulam Rehman Mohyuddin, Mohamed Al-Jumayli, Chao Huang> ;Journal of Geriatric Oncology. 2021 Feb 19
19 citations
Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines
Inamul Haque, Hameem I Kawsar, Hannah Motes, Mukut Sharma, Snigdha Banerjee, Sushanta K. Banerjee, Andrew K. Godwin, Chao H. Huang> ;International Journal of Molecular Sciences. 2020 Dec 6
118 citations
Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers.
Takefumi Komiya, Chao H. Huang> ;Frontiers in Oncology. 2018 Oct 4
4 citations
Positivity Rates in Oropharyngeal and Nonoropharyngeal Head and Neck Cancer in the VA.
John L. Park, Veronica McPike, Suman Kambhampati, Chao Huang, January Fields-Meehan, Linda Verkruyse, Ace Allen, Eashwer Reddy> ;Federal Practitioner. 2018 Aug 1
76 citations
Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway.
Chao Huang, Kiera Fisher, Sandra S Hammer, Svetlana Navitskaya, Gary J. Blanchard, Julia V. Busik> ;Diabetes. 2018 May 28
12 citations
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.
David E. Gerber, Mark A. Socinski, Joel W. Neal, Heather A. Wakelee, Keisuke Shirai, Lecia V. Sequist, Rachel P. Rosovsky, Rogerio Lilenbaum, Bruno R. Bastos, Chao Hua...> ;Lung Cancer. 2018 Mar 1
20 citations
The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review
Inamul Haque, Arvind Subramanian, Chao H. Huang, Andrew K. Godwin, Peter J. Van Veldhuizen, Snigdha Banerjee, Sushanta K. Banerjee> ;International Journal of Molecular Sciences. 2017 Dec 31
Joint Reconstruction of Absorbed Optical Energy Density and Sound Speed Distributions in Photoacoustic Computed Tomography: A Numerical Investigation.
Huang, C.,Wang, K.,Schoonover, R. W.,Wang, L. V.,Anastasio, M. A.> ;IEEE Trans Comput Imaging. 2016 Jun 01
8 citations
Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer.
Chao H. Huang, Stephen K. Williamson, Prakash Neupane, Sarah A. Taylor, Ace Allen, Nora J. Smart, Adelina M. Uypeckcuat, Sarah Spencer, Jo Wick, Holly J. Smith, Peter ...> ;Frontiers in Oncology. 2016 Jan 13
2 citations
Systematic analysis of design and stratification for phase III trials in first‐line advanced non‐small cell lung cancer
Takefumi Komiya, Raymond P. Perez, Kirsten D. Erickson, Chao H. Huang> ;Thoracic Cancer. 2016 Jan 1
1 citations
Infrequent chemoradiation-induced acute esophagitis in the Asian population: A meta-analysis of published clinical trials for unresectable stage III non-small cell lun...
Takefumi Komiya, Shana L. Palla, Feng Wang, Raymond P. Perez, Chao H. Huang> ;Thoracic Cancer. 2014 Nov 1
31 citations
A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer
Chao H. Huang, Jo Wick, Gurusingham Sitta Sittampalam, Victor Sanjit Nirmalanandhan, Apar Kishor Ganti, Prakash Neupane, Stephen K. Williamson, Andrew K. Godwin, Sarah...> ;Frontiers in Oncology. 2014 Oct 14
342 citations
Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer
Ezra E.W. Cohen, Theodore Karrison, Masha Kocherginsky, Jeffrey Mueller, Robyn Egan, Chao H. Huang, Bruce Brockstein, Mark Agulnik, Bharat B. Mittal, Furhan Yunus, San...> ;Journal of Clinical Oncology. 2014 Sep 1
Dissociation of rugose-dependent short-term memory component from memory consolidation in Drosophila.
Zhao, J.,Lu, Y.,Zhao, X.,Yao, X.,Shuai, Y.,Huang, C.,Wang, L.,Jeong, S. H.,Zhong, Y.> ;Genes Brain Behav.. 2013 Aug
5 citations
Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420.
Smita Mehta, James C. Moon, Mehmood Hashmi, Michael LeBlanc, Chao Hui Huang, Elizabeth Rinehart, Gregory T. Wolf, Susan G. Urba, Sushanta K. Banerjee, Stephen K. Willi...> ;Oncology Reports. 2013 Jun 1
101 citations
Full-Wave Iterative Image Reconstruction in Photoacoustic Tomography With Acoustically Inhomogeneous Media
Chao Huang, Kun Wang, Liming Nie, Lihong V. Wang, Mark A. Anastasio> ;IEEE Transactions on Medical Imaging. 2013 Mar 22
9 citations
Accelerating image reconstruction in three-dimensional optoacoustic tomography on graphics processing units.
Kun Wang, Chao Huang, Yu-Jiun Kao, Cheng-Ying Chou, Alexander A Oraevsky, Mark A Anastasio> ;Medical Physics. 2013 Feb 1
27 citations
Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer
Heather Male, Vijay Patel, Mark A. Jacob, Emma Borrego-Diaz, Kun Wang, Derek A. Young, Amanda L. Wise, Chao Huang, Peter J. Van Veldhuizen, Amy O'Brien-Ladner, Stephen...> ;Lung Cancer. 2012 Aug 1
4 citations
The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lun...
Chao H. Huang, Benjamin C. Powers> ;Clinical Medicine Insights. Oncology. 2012 Mar 12
12 citations
Potential Role of Platelet-Derived Growth Factor Receptor Inhibition Using Imatinib in Combination with Docetaxel in the Treatment of Recurrent Non-small Cell Lung Cancer
Chao H. Huang, Stephen K. Williamson, Peter J. Van Veldhuizen, Chung-Tsen Hsueh, Ace Allen, Ossama Tawfik, Jo Wick, Holly J. Smith, Adelina M. Uypeckcuat, Matthew S. M...> ;Journal of Thoracic Oncology. 2011 Feb 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

The University of Kansas HospitalKansas City, Kansas
Eastern Kansas HCSTopeka, Kansas
Dwight D. Eisenhower Veterans Affairs Medical CenterLeavenworth, Kansas

ChaoHuiHuangMDFACP

Dr. Huang is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.